Markers for assessment of nodal metastasis in laryngeal carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 4, 1997, Pages 412-419

  Takes, Robert P ^a   Baatenburg De Jong, Robert J ^a   Schuuring, Ed ^a   Hermans, Jo ^a   Vis, André A ^a   Litvinov, Sergey V ^a   Van Krieken, J Han J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYCLIN D1; CYCLINE; DESMOPLAKIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 2; PROTEIN P53; UVOMORULIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; ONCOGENE MYC; ONCOGENE NEU; TUMOR SUPPRESSOR GENE;

EID: 8244242537     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900040048008     Document Type: Article

References (56)

1. Batsakis JG. Tumors of the Head and Neck. 2nd ed. Baltimore, Md: Williams & Wilkins; 1979.
2. van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology. 1991;180:457-461.
3. Schuller DE, Reiches NA, Hamaker RC, et al. Analysis of disability resulting from treatment including radical neck dissection or modified neck dissection. Head Neck Surg. 1983;6:551-558.
4. Remmler D, Byers R, Scheetz J, et al. A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg. 1986;8:280-286.
5. Patten C, Hillel AD. The 11th nerve syndrome: accessory nerve palsy or adhesive capsulitis? Arch Otolaryngol Head Neck Surg. 1993;119:215-220.
6. Close LG, Merkel M, Vuitch MF, Reisch J, Schaefer SD. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx. Head Neck. 1989;11:309-317.
7. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol. 1993;250:11-17.
8. van den Brekel MW, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg. 1991;117:663-673.
9. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol. 1992;28B:67-76.
10. Clark LJ. Oncogenes and ENT: a review of the molecular biological advances in squamous cell carcinoma of the head and neck. Clin Otolaryngol. 1993;18: 4-13.
11. Issing WJ, Wustrow TP, Heppt WJ. Oncogenes related to head and neck cancer. Anticancer Res. 1993;13:2541-2551.
12. Somers KD, Schechter GL. Genetic alterations in head and neck cancer. Otolaryngol Clin North Am. 1992;25:1065-1071.
13. Baatenburg de Jong RJ, Knegt P, Verwoerd CD. Reduction of the number of neck treatments in patients with head and neck cancer. Cancer. 1993;71:2312-2318.
14. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 1992;7:355-361.
15. Frierson HF, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 1986;17:346-354.
16. Rasgon BM, Cruz RM, Hilsinger RL Jr, Sawicki JE. Relation of lymph-node metastasis to histopathologic appearance in oral cavity and oropharyngeal carcinoma: a case series and literature review. Laryngoscope. 1989;99:1103-1110.
17. Iwasaki K, Motomichi T, Fujimara T. Malignant tumor and eosinophils, 1 : prognostic significance in gastric cancer. Cancer. 1986;58:1321-1327.
18. Lowe D, Fletcher CDM. Eosinophilia in squamous cell carcinoma of the oral cavity, external genitalia and anus: clinical correlations. Histopathology. 1984; 8:627-632.
19. Goldsmith MM, Belchis DA, Cresson DH, Merritt WD, Askin FB. The importance of the eosinophil in head and neck cancer. Otolaryngol Head Neck Surg. 1992;106:27-33.
20. Thompson AC, Bradley PJ, Griffin NR. Tumor-associated tissue eosinophilia and long term prognosis for carcinoma of the larynx. Am J Surg. 1994;168: 469-471.
21. Sassler AM, McClatchey KD, Wolf GT, Fisher SG. Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma. Laryngoscope. 1995;105:413-416.
22. Shear M, Hawkins DM, Farr HW. The prediction of lymph node metastases from oral squamous carcinoma. Cancer. 1976;37:1901-1907.
23. Jones AS. Prognosis in mouth cancer: tumour factors. Eur J Cancer B Oral Oncol. 1994;30B:8-15.
24. Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg. 1984; 6:938-947.
25. Shingaki S, Suzuki I, Nakajima T, Kawasaki T. Evaluation of histopathologic parameters in predicting cervical lymph node metastasis of oral and oropharyngeal carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1988; 66:683-688.
26. Schuuring E, Verhoeven E, van Tinteren H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 1992;52:5229-5234.
27. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res. 1989;49:5505-5508.
28. Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N, Abe O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res. 1991;51:1504-1508.
29. Mori M, Tokino T, Yanagisawa A, Kanamori M, Kato Y, Nakamura Y. Association between chromosome 11q13 amplification and prognosis of patients with oesophaoeal carcinomas. Eur J Cancer. 1992;28A:755-757.
30. Somers KD, Cartwright SL, Schechter GL. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene. 1990;5:915-920.
31. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head fleck Surg. 1993;119:1238-1243.
32. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813-4817.
33. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCDN1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152-158.
34. Muller D, Millon R, Lidereau R, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol. 1994;130B:113-120.
35. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes. Gene. 1995; 59:83-96.
36. Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst. 1992;84:1251-1256.
37. Logothetis CJ, Xu H, Ro JY, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst. 1992;84:1256-1261.
38. Cance WG, Brennan MF, Dudas ME, Huang C, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med. 1990;323:1457-1462.
39. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol. 1995;146:1161-1169.
40. Ishitoya J, Toriyama M, Oguchi N, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer. 1989;59:559-562.
41. Maurizi M, Scambia G, Benedetti Panici P, et al. EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer. 1992;52:862-866.
42. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi VD, Deo MG. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Eur J Cancer B Oral Oncol. 1992;28B:139-143.
43. Partridge M, Gullick WJ, Langdon JD, Sherriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1988;26:381-389.
44. Edwards DP, Grzyb KT, Dressler LG, et al. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res. 1986;46:1306-1317.
45. Litvinov SV, Velders MP, Bakker HAM, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol. 1994;125:437-446.
46. Litvinov SV, Bakker HAM, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun. 1994;2:1-11.
47. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991;51:6328-6337.
48. Schipper JH, Unger A, Jahnke K. E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol. 1994;19:381-384.
49. Bowie GL, Caslin AW, Roland NJ, Field JK, Jones AS, Kinsella AR Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol. 1993;18:196-201.
50. Birchmeier W, Weidner KM, Hulsken J, Behrens J. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol. 1993;4:231-239.
51. Birchmeier W, Behrens J, Weidner KM, Frixen UH, Schipper J. Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol. 1991;3: 832-840.
52. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451-1455.
53. Steeg PS, Cohn KH, Leone A. Tumor metastasis and nm23: current concepts. Cancer Cells. 1991;3:257-262.
54. Hennesy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991;83:281-285.
55. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer. 1993; 55:66-71.
56. Scholnick SB, Sun PC, Shaw ME, Haughey BH, el-Mofty SK. Frequent loss of heterozygosity for Rb0 TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx. Cancer. 1994;73:2472-2480.